Head and neck/thyroid pathway

 Key personnel

  • Chair - Mr Peter Clarke, a consultant otolaryngologist and head and neck surgeon at Charing Cross Hospital and The Royal Marsden NHS Foundation Trust 
  • Project manager - Elizabeth Pegers

Introduction to the pathway group

The head and neck pathway group aims to improve patient access, experience and outcomes for patients with head, neck and thyroid cancers across south and west London. The membership of the group brings together specialist expertise from primary, secondary and tertiary care as well as patients and users to enable development of high quality patient centred care.

The head and neck pathway group supports the aims and objectives of the LCA in providing world class cancer services across south and west London. It aims to improve cancer patients' experience and outcomes through delivering excellence in clinical care, research, innovation and education with particular emphasis on earlier diagnosis for head and neck/thyroid cancers.


  • Implement LCA service plan for head and neck/thyroid cancer
  • To set standards and accreditation criteria to ensure a standardised, high quality, patient centered  approach to the management of head and neck/thyroid cancers across all providers within the LCA
  • To develop and agree metrics that demonstrate quality and outcomes
  • To standardise approaches to service delivery where appropriate
  • Improve early diagnosis by delivering innovative referral guidelines agreed with primary care
  • Establish systems for monitoring peer review, clinical lines of inquiry, quality standards and outcome measures and where these are not achieved agree a process of corrective measures 
  • Embed enhanced recovery programs in all units to improve patient experience and reduce length of stay
  • Encourage and increase participation of units in local research and national clinical trials
  • Work with Thames Cancer Registry and MDTs to improve data returns of newly diagnosed cancers
  • Work with the LCA cross cutting groups to address issues relevant to the head and neck/thyroid pathway
  • Provide information as required by the Clinical Board to escalate concerns.


  • Development and implementation of a comprehensive and seamless exemplar head and neck/thyroid pathway across the LCA based upon national and international standards, research, evidence
  • Deliver the recommendations in the Model of Care
  • Improve cancer patients' experience and outcomes through delivering excellence in clinical care, research, innovation and education
  • To improve care and ensure equitable access to specialists, GPs, hospitals and healthcare professionals thus improving the outcomes of the population of London.
Close ×